To view this email as a web page, click here.

 
You’re reading the latest aesthetic insights from Dermatology Times. For more aesthetic news, visit our dedicated pages.
 
Neurotoxin news: The DAXI differentiator
image description here DAXI clinical trials suggest duration as differentiator with Revance’s proprietary peptide technology.

 
Botulinum toxin A for wound healing
image description here Small study suggests injections may improve skin scarring.

 
image description here POLL: If approved, will you use DAXI in your practice?

 
ADVERTISEMENT
Don't Miss The Aesthetics Innovation Summit on May 15!
Join other clinical, corporate and capital leaders at AIS - taking place in New Orleans, LA. Exchange information on emerging trends and learn about exciting new drugs, devices and technologies. Register Today!
 
From our Latest Issue
 
Dermatology Times cover
Dermatologists as co-conspirators?
 
The study of skin through the centuries
 
Energy-based therapies for treating GSM disorders
 
JOB OPPORTUNITIES
 
 
ADVERTISEMENT
Ad description here
 

This is a post-only, outbound email. Please do not reply to this email as we will be unable to respond to your reply. Please use the links provided if you have questions or concerns regarding this email or your subscription.